NY-UPTIME-INSTITUTE
30.7.2024 12:03:28 CEST | Business Wire | Press release
Uptime Institute today announced the release of its 14th Annual Global Data Center survey. The increased demand for digital services with both volume and compute intensity is challenging the power and cooling capabilities of much of the existing infrastructure. To meet the rising demand, data center operators and their IT clients are both investing and innovating more in their IT services and facilities and using external services. The effectiveness and impact of these investments will serve to shape the industry in the years ahead.
“Our data shows operators poised for major changes ahead on multiple levels,” said Andy Lawrence, executive director of research, Uptime Intelligence. “In 2024, we see the challenges of increased demand impacting power and cooling capabilities of existing facilities and the need for further investment to keep up with the demand. At the same time the industry needs to focus on continued staffing challenges to match capacity growth. And regulatory requirements are here and cannot be dismissed.”
Now in its 14th year, Uptime Institute’s annual survey remains the most comprehensive and longest-running study of its kind. The findings of this report highlight the practices and experiences of data center owners and operators in the areas of resiliency, sustainability, efficiency, staffing, cloud and artificial intelligence. It provides detailed insights into the digital infrastructure landscape and a view into its future trajectory. Key findings from the 2024 report include:
- Fewer than one half of data center owners and operators are tracking the metrics needed to assess their sustainability and/or meet pending regulatory requirements.
- Most operators recognize the benefits of AI and its potential. But despite many operators planning to host the technology, trust in AI for use in data center operations has declined for the third year in a row.
- The frequency and severity of data center outages remain mainly unchanged from 2023 or show small improvements. Operators are countering increases in complexity, density and extreme weather with investment and good management practices.
- Average server rack densities are increasing but remain below 8 kilowatts (kW). Most facilities do not have racks above 30kW, and those that do have only a few. This is expected to change in coming years.
- Enterprises continue to meet their IT needs with hybrid architectures. More than one half of workloads (45%) are now off-premises, continuing the gradual trend of recent years. Many continued to maintain their own data centers.
- Staffing challenges have neither improved nor worsened from 2023. More effort is needed to expand labor pools and skillsets to match the pace of capacity growth.
- Average PUE levels remain mostly flat for the fifth consecutive year, but this conceals advances in newer, larger facilities.
About the Survey:
Uptime conducted this year’s annual Global Data Center Survey online and by email in the first half of 2024. The survey participants represent a wide range of industry verticals in multiple countries. Responses were collected from a total of 879 end users registered for the survey and answered at least one question. More than one half are located in North America and Europe. Approximately one third of respondents work for professional IT/data center service providers (staff with operational or executive responsibilities for a third-party data center), such as those offering colocation, wholesale, software or cloud computing services.
Learn More:
Download the executive summary report here and register for the webinar here covering key trends and takeaways from the survey results on July 31st at 9:00 AM PDT (9:00 AM PDT, 12:00 PM EDT, and 5:00 PM BST). To join our Uptime Institute Bright Talk Channel, go to https://www.brighttalk.com/join/.
About Uptime Institute
Uptime Institute is the Global Digital Infrastructure Authority. With over 3,500 awards issued in over 118 countries around the globe, and over 1,000 currently active projects in 80+ countries, Uptime has helped tens of thousands of companies optimize critical IT assets while managing costs, resources, and efficiency.
For over 30 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their individual business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers. Offerings include the organization’s Tier Standard and Certifications, Management & Operations reviews and assessments including SCIRA-FSI financial sector risk assessment, the Sustainability Assessment and a broad range of additional risk management, performance, availability, and related offerings. Uptime Education training programs have been successfully completed by over 90,000 data center professionals, expanded by the acquisition of CNet Training, Ltd.
Uptime Institute is headquartered in New York, NY, with main offices in London, Sao Paulo, Dubai, Riyadh, Singapore, and Taipei, and full-time Uptime professionals based in over 34 countries around the world. For more information, please visit uptimeinstitute.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730874079/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
